Impact of Persistent Left Superior Vena Cava on Outcomes With Atrial Fibrillation Ablation
Pacing and Clinical Electrophysiology · 2025
DOI: 10.1111/pace.70047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pacing and Clinical Electrophysiology, 2025. Verfasst von Claire Sorensen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Education, University of Kansas School of Medicine, Kansas City, Kansas, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Persistent Left Superior Vena Cava. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Background
A persistent left superior vena cava (PLSVC) can be a trigger for atrial fibrillation (AF).
Objective
We aimed to compare post‐ablation 1‐year freedom from recurrent atrial tachycardia (AT)/AF in PLSVC patients with a matched population without PLSVC (n‐PLSVC).
Methods
A single‐center, retrospective, case–control study between 2008 and 2022. Pre‐ablation imaging identified patients with PLSVC. Propensity score matching for age, sex, BMI, type of AF, AF ablation energy type, left atrial volume, and year of ablation was performed to identify five controls for each PLSVC patient. We excluded patients who had less than 1 year of follow‐up post‐ablation or underwent prior surgical ablation.
Results
There were 90 total patients including 15 PLSVC patients and 75 matched controls (60 ± 10 years old, 31% women, 58% paroxysmal, 62% radiofrequency). One‐year freedom from AF was lower with PLSVC (27%) than n‐PLSVC (59%, p = 0.02). The PLSVC was targeted for ablation in 5/15 patients (33%), all of whom had recurrent AT/AF within 1 year. Redo AF ablations were performed in 40% (6/15) of PLSVC patients. Freedom from AF at last follow‐up (median 2.1, IQR 0.5–4.0 years) was 83% in PLSVC patients who underwent redo ablation. The only complication was right atrial lead dysfunction post‐ablation requiring lead revision.
Conclusion
Although the post‐ablation freedom from AF is lower in patients with PLSVC than n‐PLSVC, repeat ablation can result in a high freedom from AF in patients with PLSVC. Further study is necessary to determine the optimal methods and role for PLSVC ablation (including the role for pulse‐field ablation).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Education, University of Kansas School of Medicine, Kansas City, Kansas, USA.
- Department of Cardiovascular Medicine, The University of Kansas Medical Center, Kansas City, Kansas, USA.
- Department of Biostatistics and Data Science, University of Kansas School of Medicine, Kansas City, Kansas, USA.
ORCID-Profile: Claire Sorensen, Seth H Sheldon
Zitieren
APA
Sorensen, C., Shahab, A., Hu, J., Dendi, R., Emert, M., Noheria, A., Pimentel, R., Ramirez, R., Reddy, Y. M., & Sheldon, S. H. (2025). Impact of Persistent Left Superior Vena Cava on Outcomes With Atrial Fibrillation Ablation. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.70047
Vancouver
Sorensen C, Shahab A, Hu J, Dendi R, Emert M, Noheria A, et al. Impact of Persistent Left Superior Vena Cava on Outcomes With Atrial Fibrillation Ablation. Pacing and Clinical Electrophysiology. 2025. doi:10.1111/pace.70047
BibTeX
@article{Sorensen2025,
author = {Sorensen, Claire and Shahab, Ahmed and Hu, Jinxiang and Dendi, Raghu and Emert, Martin and Noheria, Amit and Pimentel, Rhea and Ramirez, Rigoberto and Reddy, Y Madhu and Sheldon, Seth H},
title = {Impact of Persistent Left Superior Vena Cava on Outcomes With Atrial Fibrillation Ablation},
journal = {Pacing and Clinical Electrophysiology},
year = {2025},
doi = {10.1111/pace.70047}
}
EUVIMED